Literature DB >> 34311279

Volatile phenolics: A comprehensive review of the anti-infective properties of an important class of essential oil constituents.

Aijaz Ahmad1, Ishaku Leo Elisha2, Sandy van Vuuren3, Alvaro Viljoen4.   

Abstract

Historically, essential oils and their lead molecules have been extensively recognised for their anti-infective properties. In this context, certain volatile phenolics (VPs) have emerged as important antimicrobial compounds with excellent inhibitory activity against pathogenic bacteria and fungi, which further extends to drug-resistant and biofilm-forming micro-organisms. In this review, we aim to collate and discuss a number of published papers on the anti-infective activities of naturally occurring VPs with special emphasis on eugenol, isoeugenol, thymol and carvacrol, using Scopus Web of Science and PubMed databases. The biosynthesis and extraction of these VPs are discussed, while particular attention is given to their broad-spectrum antimicrobial activity and the mechanisms of action. We highlight combinational studies of the VPs with other phytocompounds and with commercially available drugs, which may be a promising and a rewarding future approach to combat antimicrobial resistance. These VPs alone, or concomitantly with other compounds or drugs, have the potential to be incorporated into different formulations for biomedical applications. An in-depth assessment of 2310 articles retrieved from the Scopus database spanning a 35-year period indicated 23.1% increase in global publication growth in VPs anti-infective research, with authors from Italy, Portugal and Austria dominating the research landscape. The dominant areas of investigations are identified as antimicrobial activity, antibacterial mechanism of action, antifungal mechanism of action, extraction methods and phytochemistry, use in the food industry, and for oral and dental anti-infective activity. Specific research areas, which require future attention include; antituberculosis research, nanoparticle formulation of antimicrobial active VP molecules, preclinical and clinical trials. The antimicrobial testing of isoeugenol was found to be the least studied of the VPs and this requires further attention.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial mechanism of action; Bibliometric analysis; Carvacrol; Essential oil; Eugenol; Isoeugenol; Scientometrics; Thymol; VOSviewer; Volatile phenolics

Year:  2021        PMID: 34311279     DOI: 10.1016/j.phytochem.2021.112864

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  4 in total

1.  Heracleum persicum Essential Oil Nanoemulsion: A Nanocarrier System for the Delivery of Promising Anticancer and Antioxidant Bioactive Agents.

Authors:  Shima Ghareh Bashlouei; Ehsan Karimi; Mohsen Zareian; Ehsan Oskoueian; Majid Shakeri
Journal:  Antioxidants (Basel)       Date:  2022-04-25

2.  Design, Synthesis, Antibacterial, Antifungal and Anticancer Evaluations of Novel β-Pinene Quaternary Ammonium Salts.

Authors:  Li Zhang; Xue-Zhen Feng; Zhuan-Quan Xiao; Guo-Rong Fan; Shang-Xing Chen; Sheng-Liang Liao; Hai Luo; Zong-De Wang
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

3.  Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles.

Authors:  Rossella Grande; Simone Carradori; Valentina Puca; Irene Vitale; Andrea Angeli; Alessio Nocentini; Alessandro Bonardi; Paola Gratteri; Paola Lanuti; Giuseppina Bologna; Pasquale Simeone; Clemente Capasso; Viviana De Luca; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 4.  Essential Oils as Multicomponent Mixtures and Their Potential for Human Health and Well-Being.

Authors:  Marek Bunse; Rolf Daniels; Carsten Gründemann; Jörg Heilmann; Dietmar R Kammerer; Michael Keusgen; Ulrike Lindequist; Matthias F Melzig; Gertrud E Morlock; Hartwig Schulz; Ralf Schweiggert; Meinhard Simon; Florian C Stintzing; Michael Wink
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.